Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Nešković-Konstantinović Zora"'
Publikováno v:
Opšta Medicina, Vol 22, Iss 1-2, Pp 36-46 (2016)
On the ground of the available data, this paper presents the problem of malignant diseases in Central Serbia, and most common carcinogens. Division of carcinogens, cancerogenesis and natural history of disease, early detection of cancer and palliativ
Externí odkaz:
https://doaj.org/article/0b9707aebd6a45599786a1aefff1a3b5
Autor:
Berat Svetlana, Nešković-Konstantinović Zora, Nedović Goran, Rapaić Dragan, Marinković Dragan
Publikováno v:
Vojnosanitetski Pregled, Vol 72, Iss 1, Pp 33-39 (2015)
Background/Aim. Malignant disease, its treatment and consequences of treatment can often lead to social marginalization and reduced quality of life. The aim of this research was to determine how elderly patients with malignant diseases function in
Externí odkaz:
https://doaj.org/article/9d75eef55492477099dc7d01c9717fcb
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 139, Iss 5-6, Pp 339-346 (2011)
Introduction. Breast cancer is the most frequent malignant disease in women with about 25% compared to all malignant tumours. Chemotherapy, antiestrogen and ovarian ablation/ supression present effective adjuvant approach for premenopausal women diag
Externí odkaz:
https://doaj.org/article/4f981bf7d1ba4c10a387a21f265595c8
Autor:
Mandušić Vesna, Popov-Čeleketić Dušan, Nešković-Konstantinović Zora, Kanjer Ksenija, Božović Ana, Nikolić-Vukosavljević Dragica
Publikováno v:
Archives of Biological Sciences, Vol 62, Iss 2, Pp 257-262 (2010)
It is well known that breast tumors which are estrogen positive ER(+) are more likely to respond to hormone therapy. However, a certain percentage of ER(+)/PR(+) tumors do not respond to this therapy. Identification of the second estrogen receptor, n
Externí odkaz:
https://doaj.org/article/0e991a4637934d88a8db97506983a634
Autor:
Nešković-Konstantinović Zora, Kanjer Ksenija, Borojević Nenad, Jezdić Svetlana, Gavrilović Dušica, Nikolić-Vukosavljević Dragica
Publikováno v:
Archive of Oncology, Vol 14, Iss 3-4, Pp 110-114 (2006)
Background: The expression of epidermal growth factor receptor (EGF-R) in breast cancer (BC) is generally considered as an unfavorable event during tumor progression. Its predictive role has been fairly well defined: EGF-R expression predicts tamoxif
Externí odkaz:
https://doaj.org/article/edef07772d2d43c491315fa4403dc374
Autor:
Mandušić Vesna, Nikolić-Vukosavljević Dragica, Nešković-Konstantinović Zora, Tanić Nikola, Čeleketić Dušica, Dimitrijević Bogomir
Publikováno v:
Archive of Oncology, Vol 14, Iss 3-4, Pp 106-109 (2006)
Background: Estrogen and progesterone receptor (ER/PR) status is an accepted predictive marker in breast cancer. It is well known that breast tumors, which are ER(+) are more likely to respond to endocrine therapy. However, certain percentage of ER(+
Externí odkaz:
https://doaj.org/article/6f4da93d9ea54ae1add8d80977f47581
Publikováno v:
Archive of Oncology, Vol 14, Iss 3-4, Pp 156-160 (2006)
It has generally been accepted that breast cancer (BC) cells are equally responsive to chemotherapy (CHT) irrespective of ER status. However, subset analyses of disease outcome in recently reported trials on neoadjuvant and adjuvant CHT brought new i
Externí odkaz:
https://doaj.org/article/132719facb2d468e87ec88c67fe3c8a8
Publikováno v:
Archive of Oncology, Vol 14, Iss 3-4, Pp 146-150 (2006)
In tumors in which estrogen receptor (ER) and growth factor signaling pathways are simultaneously active, there is a bidirectional cross-talk that results in a positive feedback cycle of cell survival and proliferation stimuli. Beside the postulated
Externí odkaz:
https://doaj.org/article/7bad4efd0f184c1b8cace792edaba753
Autor:
Markićević Milan, Vujasinović Tijana, Nešković-Konstantinović Zora, Nikolić-Vukosavljević Dragica
Publikováno v:
Archive of Oncology, Vol 14, Iss 3-4, Pp 151-155 (2006)
In addition to classical prognostic/predictive factors, significant biological markers have been identified to provide potentially relevant information regarding natural or clinical course of breast cancer. Steroid receptor status of the primary brea
Externí odkaz:
https://doaj.org/article/e8bb07fa36e84bc4bc12ea80853f6988
Publikováno v:
Archive of Oncology, Vol 14, Iss 3-4, Pp 141-145 (2006)
The preoperative (neoadjuvant) setting of breast cancer treatment is an optimal in vivo model by which to allow the characterization of biomarker expression pattern with the tumor remaining in situ throughout treatment as an in vivo measure of respon
Externí odkaz:
https://doaj.org/article/f2da751cf3f0413f8205b8e2d0436bb8